Trevena

Trevena Announces Two OLINVYK Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY 2021

CHESTERBROOK, PA — Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, this week announced …

Trevena Announces Two OLINVYK Abstracts Highlighting Safety Data Accepted at ANESTHESIOLOGY 2021 Read More



Galera Therapeutics

Article Shows Galera’s Selective Dismutase Mimetic Synergizes with Radiotherapy to Ablate Tumors

MALVERN, PA — Galera Therapeutics, Inc. (Nasdaq: GRTX) recently announced that Science Translational Medicine has published a foundational preclinical article describing the synergy of avasopasem manganese, one of the Company’s selective …

Article Shows Galera’s Selective Dismutase Mimetic Synergizes with Radiotherapy to Ablate Tumors Read More